Skip to main content

Day: March 28, 2023

PDS Biotech Provides Business Update and Reports Fourth-Quarter and Full-Year 2022 Financial Results

Successful meeting with FDA to discuss registrational pathway for triple combination of PDS0101, PDS0301, and a commercial immune checkpoint inhibitor 100% (9/9) clinical response (>60% tumor shrinkage at mid-point evaluation) in IMMUNOCERV trial for high-risk cervical cancer patients with tumors >5 cm in PDS0101 + CRT based on preliminary data Company to host conference call and webcast today, March 28, 2023, at 8:00 AM ETFLORHAM PARK, N.J., March 28, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (NASDAQ: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today provided a business update and announced its financial results for the year ended December 31, 2022. Fourth Quarter 2022 and Recent Business Highlights:PDS0101 Lead Drug...

Continue reading

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Announced positive interim data from the Phase 2b ORIGIN clinical trial of atacicept in IgAN, which showed a 41% mean reduction in proteinuria versus baseline in the 150mg dose group at 24 weeks 36-week data from the Phase 2b ORIGIN clinical trial of atacicept in IgAN on track for the second quarter of 2023 Management prioritizing advancement of atacicept in IgAN, plans to initiate Phase 3 clinical trial in second quarter of 2023 Strong balance sheet expected to fund IgAN-focused operations to early 2026BRISBANE, Calif., March 28, 2023 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its business highlights for the fourth quarter and financial...

Continue reading

Intermap Reports Strong 2022 Financial Results

Revenue grew 17% year over year Recurring revenue grew to 57% of total revenue, an increase of 9% over 2021 Awarded transformative U.S. government contracts and commercial software subscriptions DENVER, March 28, 2023 (GLOBE NEWSWIRE) — Intermap Technologies (TSX: IMP; OTCQX: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced financial results for 2022. For the year ending December 31, 2022, the Company reported revenue of $6.8 million, compared with $5.8 million the previous year. Intermap demonstrated 60% growth in the third quarter as COVID restrictions relaxed globally, which continued into the fourth quarter. The Company closed the year with over $2.3 million in liquidity (cash, accounts receivable and unbilled), compared with $1.7 million at the end...

Continue reading

Colliers recognized by the Globe and Mail’s fourth-annual Women Lead Here benchmark of executive gender diversity

TORONTO, March 28, 2023 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company Colliers (NASDAQ, TSX: CIGI) has been included on The Globe and Mail’s 2023 Report on Business magazine’s Women Lead Here list. This annual editorial benchmark identifies top-notch Canadian businesses with the highest executive gender diversity. This benchmark was established in 2020 by Report on Business magazine and applies a proprietary research methodology to determine Canadian corporations with the highest degree of gender diversity among executive ranks. The ranking companies have made tangible and organizational progress related to executive gender parity. “At Colliers, we are committed to a more diverse, equitable, and inclusive future,” said Becky Finley, Global Chief Brand & People Officer. “We support...

Continue reading

Resolutions by the Annual General Meeting of Municipality Finance Plc held on 28 March 2023

Municipality Finance PlcStock exchange release 28 March 2023 at 3.00 p.m. (EEST) Resolutions by the Annual General Meeting of Municipality Finance Plc held on 28 March 2023 The Annual General Meeting (hereinafter the AGM) of Municipality Finance Plc (MuniFin) held on 28 March 2023 adopted the company’s financial statements and discharged the members of the Board of Directors (the Board), the CEO, and the Deputy to the CEO from liability for the financial year 2022. Use of Profit Shown on the Balance Sheet and the Distribution of DividendThe Annual General Meeting decided that a dividend of EUR 1.73 per share, totalling 67,580,370.54 EUR shall be paid out. Dividends will be paid on 13 April 2023 to each shareholder recorded in the company’s list of shareholders on 4 April 2023. Remuneration and Composition of the Board The AGM decided...

Continue reading

The Lovesac Company Reports Record Fourth Quarter and Fiscal 2023 Financial Results

Net Sales Growth of 21.7% in Fourth Quarter and 30.8% in Fiscal 2023Comparable Sales Growth of 16.2% in Fourth Quarter and 21.9% in Fiscal 2023Net Income of $27.6 million in Fourth Quarter compared to $32.6 million in Last Year QuarterNet Income of $28.2 million in Fiscal 2023 compared to $45.9 million in Fiscal 2022Adjusted EBITDA1 Increased 51.0% to $48.3 million in Fourth Quarter from $32.0 million in Last Year QuarterAdjusted EBITDA1 Increased to $60.4 million in Fiscal 2023 from $55.5 million in Fiscal 2022 STAMFORD, Conn., March 28, 2023 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), sustainable home furnishing brand best known for its Sactionals, The World’s Most Adaptable Couch, today announced financial results for the fourth quarter and fiscal year 2023, which ended January 29,...

Continue reading

Parsons Awarded $94 Million Contract To Expand Full-Spectrum Military Cyberspace Operational Footprint

CENTREVILLE, Va., March 28, 2023 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) continues to advance full-spectrum cyber dominance, announcing today that it was selected to provide command, control, communications, computers, and capabilities development support services (C4CD-2.0) to United States Cyber Command (USCYBERCOM). The $94 million cost-plus-fixed-fee contract complements work awarded to Parsons to support the agency’s C4CD mission set and consists of one 12-month base period of performance with four 12-month option periods. “Parsons’ offerings are aligned with the National Defense Science and Technology Strategy and complement CYBERCOM’s missions that underpin the Defense Department’s strategy to innovate at speed and scale,” said Mike Kushin, Parsons’ executive vice president of high consequence missions. “We serve...

Continue reading

Better Choice Company Reports Fourth Quarter and Full Year 2022 Financial Results

Year-to-Date Net Sales Totaled $54.7 million, an Increase of 19% Year-over-Year Year-to-Date Gross Margin of 28%, or 31% Excluding the Impact of Inventory Rationalization NEW YORK, March 28, 2023 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, today reported its financial results for the fourth quarter and year ended December 31, 2022. Lionel F. Conacher, Interim CEO of Better Choice, stated, “During the fourth quarter, net sales were sales were $9.3 million resulting in full year 2022 net sales of $54.7 million, a 19% increase versus the prior year. Our International channel delivered year-over-year net sales growth of 48% and Brick & Mortar net sales grew 72% in 2022 versus the prior year fueled by the Halo Elevate launch. Driven by...

Continue reading

Rule 8.3 – Ediston Property Investment Company plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: Investec Wealth & Investment Limited(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeEdiston Property Investment Company plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: Ediston...

Continue reading

Rego Payment Architectures, Inc. Announces Integration with Q2’s Digital Banking Platform

Financial Institutions can now provide Rego Payment Architectures Inc.’s Family Wallet Banking-as-a-Platform to their users through Q2’s Digital Banking Platform BLUE BELL, Pa., March 28, 2023 (GLOBE NEWSWIRE) — Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), today announced its integration with Q2’s Digital Banking Platform, via the Q2 Partner Accelerator Program. Q2 Holdings, Inc. (NYSE: QTWO) is a leading provider of digital transformation solutions for banking and lending. As part of the Q2 Partner Accelerator Program, banks and credit unions can now purchase the solution from REGO and then offer its MazoolaEnabledSM white label/private label Family Wallet Banking-as-a-Platform to their account holders. The Q2 Partner Accelerator is a program through the Q2 Innovation Studio that allows in-demand financial services...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.